sulfapyridine has been researched along with Colitis, Ulcerative in 67 studies
Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.
Colitis, Ulcerative: Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
Excerpt | Relevance | Reference |
---|---|---|
"Drugs for the treatment of ulcerative colitis are sulphapyridine, 5-aminosalicylic acid, prednisolone, betamethasone and immunosuppressive drugs." | 2.40 | [Ulcerative colitis and intestinal bleeding]. ( Asakura, H, 1998) |
"A 29-year-old male patient with ulcerative colitis, who underwent haemodialysis thrice a week because of severe renal dysfunction." | 1.32 | Sulphasalazine-induced leucopenia in a patient with renal dysfunction. ( Hino, B; Iida, M; Itoh, Y; Joh, Y; Makino, K; Oishi, R; Teshima, D; Yano, T, 2003) |
"A 57-year-old woman with ulcerative colitis presented with obstructive nephropathy and pyelonephritis." | 1.32 | Obstructive nephropathy secondary to sulfasalazine calculi. ( Agarwal, S; Choi, MJ; Kelty, PJ; Russinko, PJ, 2003) |
"She had been suffering ulcerative colitis and administered salazosulphapyridine and predonisolone from 17-year-old." | 1.30 | [A case of drug induced urolithiasis composed of acetyl sulphapyridine associated with ulcerative colitis]. ( Kamijo, T; Nagase, Y; Yanagisawa, R, 1999) |
" A pharmacokinetic comparison of polymer and SASP showed similar deliveries of 5-ASA and metabolites to the lower bowel, blood, and urine of orally dosed rats." | 1.27 | A polymeric drug for treatment of inflammatory bowel disease. ( Brown, JP; McGarraugh, GV; Onderdonk, AB; Parkinson, TM; Wingard, RE, 1983) |
"Miniaturised methods have been used to construct dose-response curves for the effects of inhibitory drugs on prostaglandin synthesis using individual rectal biopsies obtained from patients with ulcerative colitis." | 1.27 | Inhibition of prostaglandin synthetase in human rectal mucosa. ( Hawkey, CJ; Lo Casto, M, 1983) |
"In treatment of Crohn's disease, sulfasalazine has been shown to be effective when disease involves the colon or the colon and small intestine." | 1.27 | Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine. ( Das, KM, 1983) |
" The results showed that, although there were wide individual variations in levels after oral and rectal administration, with the same dosage the levels were far higher when the drug was given orally." | 1.27 | A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route. ( Arthur, M; Ashworth, M; Smith, PR; Turmer, AD, 1984) |
"In active ulcerative colitis basal platelet-activating factor activity was 8." | 1.27 | Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. ( Eliakim, R; Karmeli, F; Rachmilewitz, D; Razin, E, 1988) |
" This suggests that, at least in some patients, the adverse effects of sulfasalazine are due to 5-aminosalicylic acid rather than sulfapyridine." | 1.27 | Adverse effects with oral 5-aminosalicyclic acid. ( Fardy, JM; Lloyd, DA; Reynolds, RP, 1988) |
" The aim of our work was to assess the levels of the drug in blood (SASP and SP), to correlate them with undesirable effects in any, to verify their fluctuations in the dosing interval and to investigate the extent of the excretion of the drug in the children who were studied." | 1.27 | [Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment]. ( Guastavino, E; Heffes Nahmod, L; Licastro, R; Litwin, NH, 1988) |
"This fall during a relapse is most pronounced when the patient suffers from universal colitis and is least marked in cases of distal colitis." | 1.26 | Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. ( Azad Khan, AK; Truelove, SC, 1980) |
"In eleven pregnant patients with ulcerative colitis or Crohn's disease who were treated with sulphasalazine (SASP) the serum concentrations of SASP and sulphapyridine (SP) were measured at delivery." | 1.26 | Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. ( Esbjörner, E; Into-Malmberg, MB; Järnerot, G, 1981) |
"Twelve pregnant patients with ulcerative colitis or Crohn's disease who were being treated with sulphasalazine (SASP) were studied together with their newborn, full-term babies." | 1.26 | Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. ( Andersen, S; Brodersen, R; Esbjörner, E; Järnerot, G; Sandström, B, 1981) |
"Seventeen patients with ulcerative colitis and three patients with Crohn's disease exhibited different side effects during sulfasalazine therapy." | 1.26 | Desensitization of patients with inflammatory bowel disease to sulfasalazine. ( Das, KM; Taffet, SL, 1982) |
"In children three forms of Crohn's disease requiring operation have been identified." | 1.26 | Inflammatory bowel disease in childhood. ( Fonkalsrud, EW, 1981) |
"Sixty-four outpatients with ulcerative colitis receiving maintenance treatment with sulphasalazine were studied to relate disease activity to serum concentrations of sulphapyridine." | 1.26 | Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. ( Cowan, GO; Das, KM; Eastwood, MA, 1977) |
"The remission period of patients with ulcerative colitis was extended by long term treatment with 2-3 g sulphasalazine daily." | 1.26 | [Long-term therapy in ulcerative colitis and Crohn's disease]. ( Malchow, H, 1979) |
" A single study of serum can determine acetylator phenotype in patients on sulfasalazine therapy without using any other drug for this purpose and may help ascertain dosage and assess side effects." | 1.25 | Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. ( Das, KM; Eastwood, MA, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (74.63) | 18.7374 |
1990's | 12 (17.91) | 18.2507 |
2000's | 4 (5.97) | 29.6817 |
2010's | 1 (1.49) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JP | 1 |
McGarraugh, GV | 1 |
Parkinson, TM | 1 |
Wingard, RE | 1 |
Onderdonk, AB | 1 |
Xiong, H | 1 |
Chen, S | 1 |
Luo, X | 1 |
Hanauer, SB | 1 |
Teshima, D | 1 |
Hino, B | 1 |
Makino, K | 1 |
Yano, T | 1 |
Itoh, Y | 1 |
Joh, Y | 1 |
Iida, M | 1 |
Oishi, R | 1 |
Russinko, PJ | 1 |
Agarwal, S | 1 |
Choi, MJ | 1 |
Kelty, PJ | 1 |
Doering, J | 1 |
Begue, B | 1 |
Lentze, MJ | 1 |
Rieux-Laucat, F | 1 |
Goulet, O | 1 |
Schmitz, J | 1 |
Cerf-Bensussan, N | 1 |
Ruemmele, FM | 1 |
Day, JM | 1 |
Houston, JB | 1 |
Azad Khan, AK | 2 |
Truelove, SC | 3 |
Klotz, U | 1 |
Maier, K | 1 |
Fischer, C | 1 |
Heinkel, K | 1 |
Rhodes, JM | 1 |
Bartholomew, TC | 1 |
Jewell, DP | 1 |
Sharp, ME | 1 |
Wallace, SM | 1 |
Hindmarsh, KW | 1 |
Brown, MA | 1 |
Holdstock, G | 1 |
Chastenay, BF | 1 |
Krawitt, EL | 1 |
Järnerot, G | 4 |
Into-Malmberg, MB | 2 |
Esbjörner, E | 3 |
Andersen, S | 1 |
Sandström, B | 1 |
Brodersen, R | 1 |
Hazenberg, MP | 1 |
Bakker, M | 1 |
Both-Patoir, HC | 1 |
Ruseler-van Embden, JG | 1 |
Schröder, AM | 1 |
Eitner, K | 2 |
Hippius, M | 2 |
Reinicke, C | 2 |
van Hees, PA | 1 |
van Tongeren, JH | 1 |
Taffet, SL | 1 |
Das, KM | 4 |
Hawkey, CJ | 3 |
Lo Casto, M | 1 |
Ashworth, M | 1 |
Arthur, M | 1 |
Turmer, AD | 1 |
Smith, PR | 1 |
Allgayer, H | 2 |
Kruis, W | 1 |
Eisenburg, J | 2 |
Paumgartner, G | 2 |
O'Moráin, C | 1 |
Smethurst, P | 1 |
Doré, CJ | 1 |
Levi, AJ | 1 |
Mian, TA | 1 |
Zuberi, SJ | 1 |
de Longraye, J | 1 |
Brard, M | 1 |
Fonkalsrud, EW | 1 |
Reynolds, PD | 1 |
Middleton, SJ | 1 |
Shorthouse, M | 1 |
Hunter, JO | 1 |
Kimura, I | 4 |
Nagahama, S | 2 |
Kawasaki, M | 3 |
Kataoka, M | 4 |
Sato, M | 1 |
Asakura, H | 1 |
Kumamoto, T | 1 |
Matsuda, A | 3 |
Kokuba, Y | 2 |
Kokurba, Y | 1 |
Yanagisawa, R | 1 |
Kamijo, T | 1 |
Nagase, Y | 1 |
Cowan, GO | 1 |
Eastwood, MA | 2 |
Sharon, P | 1 |
Ligumsky, M | 1 |
Rachmilewitz, D | 2 |
Zor, U | 1 |
Goldstein, PD | 1 |
Alpers, DH | 1 |
Keating, JP | 1 |
Molin, L | 1 |
Stendahl, O | 1 |
Khan, AK | 1 |
Piris, J | 1 |
Ewe, K | 1 |
Goldman, P | 1 |
Peppercorn, MA | 1 |
Malchow, H | 1 |
Binder, V | 2 |
Winkler, R | 1 |
Base, W | 1 |
Ferenci, P | 1 |
Pesendorfer, FX | 1 |
Aigner, O | 1 |
Wewalka, F | 1 |
Hayllar, J | 1 |
Bjarnason, I | 1 |
Mahida, YR | 1 |
Lamming, CE | 1 |
Gallagher, A | 1 |
Hawthorne, AB | 1 |
Klugmann, HJ | 1 |
Giehler, B | 1 |
Lohmann, D | 1 |
Schiedewitz, W | 1 |
Astbury, C | 1 |
Taggart, AJ | 1 |
Juby, L | 1 |
Zebouni, L | 1 |
Bird, HA | 1 |
Stone, OJ | 1 |
Donowitz, M | 1 |
Banatwala, N | 1 |
Boughton-Smith, NK | 1 |
Whittle, BJ | 1 |
MacDermott, RP | 1 |
Kane, MG | 1 |
Steele, LL | 1 |
Stenson, WF | 1 |
Bondesen, S | 1 |
Nielsen, OH | 1 |
Schou, JB | 1 |
Jensen, PH | 1 |
Lassen, LB | 1 |
Krasilnikoff, PA | 1 |
Danø, P | 1 |
Hansen, SH | 1 |
Rasmussen, SN | 1 |
Wranne, L | 1 |
Rao, SS | 1 |
Cann, PA | 1 |
Holdsworth, CD | 1 |
Goerg, KJ | 1 |
Wanitschke, R | 1 |
Gabbert, H | 1 |
Breiling, J | 1 |
Franke, M | 1 |
Meyer zum Büschenfelde, KH | 1 |
Eliakim, R | 1 |
Karmeli, F | 1 |
Razin, E | 1 |
Fardy, JM | 1 |
Lloyd, DA | 1 |
Reynolds, RP | 1 |
Guastavino, E | 1 |
Litwin, NH | 1 |
Heffes Nahmod, L | 1 |
Licastro, R | 1 |
Okada, M | 1 |
Yao, T | 1 |
4 reviews available for sulfapyridine and Colitis, Ulcerative
Article | Year |
---|---|
[Ulcerative colitis and intestinal bleeding].
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, U | 1998 |
Drug therapy: Sulfasalazine.
Topics: Animals; Bacteria; Binding, Competitive; Biological Transport; Chemical Phenomena; Chemistry; Coliti | 1975 |
Sulphasalazine in ulcerative colitis: in memoriam?
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Dose-Response Relationship, Drug; Humans; Mesalamine; Neu | 1991 |
Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Drug Combinations; Dr | 1985 |
3 trials available for sulfapyridine and Colitis, Ulcerative
Article | Year |
---|---|
Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Humans; M | 1980 |
An experiment to determine the active therapeutic moiety of sulphasalazine.
Topics: Administration, Topical; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Double | 1977 |
Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine.
Topics: Adult; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Female; Humans; Male; Me | 1987 |
60 other studies available for sulfapyridine and Colitis, Ulcerative
Article | Year |
---|---|
A polymeric drug for treatment of inflammatory bowel disease.
Topics: Aminosalicylic Acid; Animals; Biotransformation; Colitis, Ulcerative; Guinea Pigs; Intestines; Polym | 1983 |
Salazosulphapyridine-related Stevens-Johnson Syndrome Caused by Sulphapyridine and Confirmed by Enzyme-linked Immunospot Assay.
Topics: Colitis, Ulcerative; Enzyme-Linked Immunospot Assay; Female; Gastrointestinal Agents; Humans; Middle | 2018 |
Mea culpa.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; | 2008 |
Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Topics: Adult; Arylamine N-Acetyltransferase; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Kidney D | 2003 |
Obstructive nephropathy secondary to sulfasalazine calculi.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enterococcus faecalis; Female; Gram-Po | 2003 |
Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cells, Cultured; Child; Child | 2004 |
Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Half-Life; Humans; Intestinal Absorption; Kinetics; Male; Phenot | 1980 |
Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Female; Humans; Male; Middle Aged; Recurrence; Sulfapy | 1980 |
Inhibition of leucocyte motility by drugs used in ulcerative colitis.
Topics: Aminosalicylic Acids; Cell Movement; Chemotaxis, Leukocyte; Colitis, Ulcerative; Dose-Response Relat | 1981 |
Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
Topics: Acetylation; Adolescent; Adult; Aged; Anti-Infective Agents; Colitis; Colitis, Ulcerative; Crohn Dis | 1981 |
Increased suppressor cell activity in inflammatory bowel disease.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Hydrocortisone; In Vitro Technique | 1981 |
Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites.
Topics: Colitis; Colitis, Ulcerative; Crohn Disease; Female; Humans; Infant, Newborn; Maternal-Fetal Exchang | 1981 |
Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine.
Topics: Adult; Albumins; Bilirubin; Colitis, Ulcerative; Crohn Disease; Female; Fetal Blood; Humans; Infant, | 1981 |
Effect of sulphasalazine on the human intestinal flora.
Topics: Aminosalicylic Acids; Ampicillin; Anaerobiosis; Animals; Bacteria; Colitis, Ulcerative; Escherichia | 1982 |
[Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Sulfanilamides; Sulfapyridine; Sulf | 1982 |
Compliance to therapy in patients on a maintenance dose of sulfasalazine.
Topics: Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Pat | 1982 |
Desensitization of patients with inflammatory bowel disease to sulfasalazine.
Topics: Colitis, Ulcerative; Crohn Disease; Desensitization, Immunologic; Dose-Response Relationship, Drug; | 1982 |
Inhibition of prostaglandin synthetase in human rectal mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclooxygenase Inhibitors; Dose | 1983 |
Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine.
Topics: Aminosalicylic Acids; Bacteria; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Kinetics; Mesalam | 1983 |
A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route.
Topics: Administration, Oral; Adult; Aged; Colitis, Ulcerative; Enema; Female; Humans; Male; Middle Aged; Su | 1984 |
Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
Topics: Administration, Oral; Adult; Biological Availability; Colitis, Ulcerative; Enema; Female; Half-Life; | 1984 |
Reversible male infertility due to sulphasalazine: studies in man and rat.
Topics: Adult; Aminosalicylic Acids; Animals; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship | 1984 |
[Determination of sulfapyridine levels in serum--a possibility for the control of dose related therapy with sulfasalazine].
Topics: Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Huma | 1984 |
Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Dose-Response Relationship, Drug; Glycine max; Humans; In | 1984 |
Ulcerative colitis--a retrospective study.
Topics: Adolescent; Adult; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Precan | 1980 |
[Salazopyrine].
Topics: Colitis, Ulcerative; Sulfanilamides; Sulfapyridine | 1981 |
Inflammatory bowel disease in childhood.
Topics: Cecal Diseases; Child; Colectomy; Colitis, Ulcerative; Colostomy; Crohn Disease; Female; Humans; Ile | 1981 |
The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ul | 1995 |
[Pharmacological studies of BX661A. 5-[4-(2-carboxyethylcarbamoyl)-phenylazo]-salicylic acid disodium salt dihydrate (1). Therapeutic effects on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) model in rats].
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Anthracenes; Anti-Inflammatory Agents, Non-Ster | 1997 |
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Topics: Aminosalicylic Acids; Anti-Ulcer Agents; Colitis, Ulcerative; Cytochrome c Group; Hydrogen Peroxide; | 1998 |
Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Topics: Alanine; Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Colitis, Ulcerative; Colon; Dextran Sulfa | 1998 |
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Chemotaxis, Leukocyte; Colitis, Ulcerative; Guinea | 1998 |
[A case of drug induced urolithiasis composed of acetyl sulphapyridine associated with ulcerative colitis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Gastrointestinal Agents | 1999 |
Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Female; Humans; Male; Middle Aged; Sulfapyridine; Sulf | 1977 |
Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Culture Techniques; Depression, Chemical; Humans; Intesti | 1978 |
Crohn's disease of the colon.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; | 1979 |
Sulfapyridine metabolites in children with inflammatory bowel disease receiving sulfasalazine.
Topics: Acetylation; Adolescent; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Humans | 1979 |
The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
Topics: Adolescent; Adult; Aminosalicylic Acids; Cell Movement; Chemotaxis, Leukocyte; Colitis, Ulcerative; | 1979 |
Placental and mammary transfer of sulphasalazine.
Topics: Colitis, Ulcerative; Female; Humans; Maternal-Fetal Exchange; Milk, Human; Pregnancy; Pregnancy Comp | 1979 |
Sulphasalazine treatment during breast feeding.
Topics: Colitis, Ulcerative; Crohn Disease; Female; Humans; Lactation; Milk, Human; Pregnancy; Sulfapyridine | 1979 |
[Indications for conservative therapy of ulcerative colitis].
Topics: Adrenocorticotropic Hormone; Adult; Child; Colitis, Ulcerative; Colonic Neoplasms; Humans; Intestina | 1977 |
Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
Topics: Acetylation; Adolescent; Adult; Aged; Colitis, Ulcerative; Crohn Disease; Female; Humans; Kinetics; | 1975 |
[Long-term therapy in ulcerative colitis and Crohn's disease].
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Metronidazole; Patie | 1979 |
[Chronic inflammatory intestinal diseases in childhood].
Topics: Child; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Glucocorticoids; Humans; Sulfapyridine | 1978 |
[Ulcerative colitis and pregnancy. Surgical treatment of acute complications (author's transl)].
Topics: Adult; Age Factors; Colectomy; Colitis, Ulcerative; Colostomy; Female; Gastrointestinal Hemorrhage; | 1976 |
[Nutritional problems in diseases of the small and large intestine].
Topics: Adolescent; Adult; Aged; Amino Acids; Body Weight; Colitis, Ulcerative; Crohn Disease; Female; Fissu | 1976 |
5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Colitis, Ulcerative; Colon; Crohn Disease; Dex | 1991 |
[Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
Topics: Administration, Oral; Adult; Aged; Colitis, Ulcerative; Dose-Response Relationship, Drug; Female; Hu | 1990 |
Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
Topics: Adult; Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Female; Humans; Male; Middle Aged; | 1990 |
Sulfapyridine and sulfones decrease glycosaminoglycans viscosity in dermatitis herpetiformis, ulcerative colitis, and pyoderma gangrenosum.
Topics: Clofazimine; Colitis, Ulcerative; Dermatitis Herpetiformis; Glycosaminoglycans; Humans; Leprosy; Pyo | 1990 |
Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Biological Transport; Bradykinin; Colitis | 1985 |
Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Autoradiography; Chromatography, Thin Lay | 1985 |
Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients.
Topics: Catechols; Colitis, Ulcerative; Crohn Disease; Cytotoxicity, Immunologic; Humans; Hydrocortisone; In | 1986 |
Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Humans; Kinetics; Male; | 1986 |
Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation.
Topics: Colitis, Ulcerative; Crohn Disease; Female; Humans; Infant, Newborn; Lactation; Maternal-Fetal Excha | 1987 |
Azodisalicylate (azodisal sodium) causes intestinal secretion. Comparative study of the effect of azodisalicylate, sulfasalazine, 5-aminosalicylic acid and sulfapyridine on the water and electrolyte transfer and the morphology of the rat ileum and colon i
Topics: Aminosalicylic Acids; Animals; Colitis, Ulcerative; Colon; Ileum; Intestinal Absorption; Intestinal | 1987 |
Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Topics: Adult; Aminosalicylic Acids; Calcimycin; Colitis, Ulcerative; Colon; Drug Combinations; Female; Gluc | 1988 |
Adverse effects with oral 5-aminosalicyclic acid.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Desensitization, Immunologic; Drug Hypersensitivit | 1988 |
[Ulcerative colitis in children. Levels of salicylazosulfapyridine and sulfapyridine during treatment].
Topics: Adolescent; Child; Colitis, Ulcerative; Humans; Sulfanilamides; Sulfapyridine; Sulfasalazine | 1988 |
[Inflammatory bowel disease; internal therapy].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Drug Combinations | 1988 |